Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for <i>PIK3CA</i>-altered head and neck cancer
Matthew L. Hedberg(Carnegie Mellon University), Jennifer R. Grandis(University of California, San Francisco)
Cited by 57
Related Papers
Head and neck squamous cell carcinoma
|Nature Reviews Disease Primers|2020|4k
Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma
|Journal of Clinical Investigation|2015|200
Cross-talk between G Protein–Coupled Receptor and Epidermal Growth Factor Receptor Signaling Pathways Contributes to Growth and Invasion of Head and Neck Squamous Cell Carcinoma
|Cancer Research|2006|147
Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma
|Journal of Clinical Investigation|2016|73